Concomitant Genetic Alterations With Response to Treatment and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR-Mutant Advanced Non-Small Cell Lung Cancer

被引：148
|
作者：
Hong, Shaodong [1 ,2 ,3 ]
Gao, Fangfang [1 ,2 ,3 ]
Fu, Sha [4 ]
Wang, Yan [5 ]
Fang, Wenfeng [1 ,2 ,3 ]
Huang, Yan [1 ,2 ,3 ]
Zhang, Li [1 ,2 ,3 ]
机构：
[1] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[2] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, 651 Dongfeng East Rd, Guangzhou 510060, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Dept Pathol, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China
[5] Quest Genom, Nanjing, Jiangsu, Peoples R China
来源：
JAMA ONCOLOGY | 2018年 / 4卷 / 05期
基金：
国家重点研发计划;
关键词：
CHEMOTHERAPY; METAANALYSIS; IMPACT;
D O I：
10.1001/jamaoncol.2018.0049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：739 / 742
页数：5
相关论文
共 50 条
  • [21] Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors.
    Aydiner, Adnan
    Dogan, Izzet
    Khanmammadov, Nijat
    Saip, Pinar
    Vatansever, Sezai
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [22] Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
    Kim, Soomin
    Koh, Jaemoon
    Kim, Tae Min
    Oh, Songji
    Kim, Soyeon
    Youk, Jeonghwan
    Kim, Miso
    Keam, Bhumsuk
    Jeon, Yoon Kyung
    Kim, Dong-Wan
    Heo, Dae Seog
    ISCIENCE, 2025, 28 (02)
  • [23] Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients
    Chen, Kaiyan
    Yu, Xiaoqing
    Wang, Haiyang
    Huang, Zhiyu
    Xu, Yanjun
    Gong, Lei
    Fan, Yun
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (06) : 1179 - 1187
  • [24] Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer
    Zaarour, Mazen
    Weerasinghe, Chanudi
    Nazha, Bassel
    Hassan, Samer
    Atallah, Jean-Paul
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (11) : 1327 - 1336
  • [25] Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients
    Kaiyan Chen
    Xiaoqing Yu
    Haiyang Wang
    Zhiyu Huang
    Yanjun Xu
    Lei Gong
    Yun Fan
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 1179 - 1187
  • [26] Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer
    Tan, Chee-Seng
    Cho, Byoung-Chul
    Soo, Ross A.
    LUNG CANCER, 2016, 93 : 59 - 68
  • [27] Cell Free Tumor DNA to Monitor Response to Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
    Ulivi, Paola
    Chiadini, Elisa
    Marisi, Giorgia
    Ludovini, Vienna
    De Luigi, Nicoletta
    Dazzi, Claudio
    Mariotti, Marita
    Crino, Lucio
    Delmonte, Angelo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1208 - S1208
  • [28] The BIM Deletion Polymorphism in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors
    Lee, Ji Yun
    Ku, Bo Mi
    Lim, Sung Hee
    Kim, Haesu
    Yoo, Kwai Han
    Jung, Ki Sun
    Song, Haa-Na
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S580 - S580
  • [29] Efficacy of cranial radiotherapy prior to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer patients with brain metastases
    Tsushita, N.
    Goto, Y.
    Shiraishi, H.
    Tsuruoka, K.
    Yoshida, K.
    Itahashi, K.
    Asao, T.
    Kitahara, S.
    Kanda, S.
    Horinouchi, H.
    Fujiwara, Y.
    Nokihara, H.
    Yamamoto, N.
    Ohe, Y.
    ANNALS OF ONCOLOGY, 2015, 26 : 143 - 143
  • [30] Tyrosine Kinase Inhibitors and Epidermal Growth Factor Receptor (EGFR) Mutations in Non-Small Cell Lung Cancer To Test or Not to Test?
    Gazdar, Adi F.
    MEDICINE, 2011, 90 (03) : 168 - 170
12345